Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration

Hemodialysis International

Volumn 20, Issue 4, 2016, Pages 610-617

  Kandouz, Sakina ^a   Mohamed, Ali Shendi ^a,b   Zheng, Yishan ^c   Sandeman, Susan ^c   Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ZAGAZIG UNIVERSITY   (Egypt)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

haemodiafiltration; Indoxyl sulfate; p cresyl sulfate; residual renal function; vegetarian

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INDICAN; NITROGEN; UREA; UREMIC TOXIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DIALYSIS; FEMALE; HEMODIAFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROBIOME; PROTEIN INTAKE; VEGETARIAN; VEGETARIAN DIET;

EID: 84991083779     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12414     Document Type: Article

References (34)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the haemodialysis prescription of patient morbidity: Report from the National Cooperative Dialysis Study. N Engl J Med. 1981; 305:1176–1181.
2. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985; 28:526–534.
3. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance haemodialysis. N Engl J Med. 2002; 347:2010–2019.
4. Davenport A, Jones SR, Goel S, Astley JP, Hartog M. Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin. Lancet. 1993; 341:1614–1617.
5. Davenport A, Jones S, Goel S, Astley JP, Feest TG. Carbamylated hemoglobin: A potential marker for the adequacy of haemodialysis therapy in end-stage renal failure. Kidney Int. 1996; 50:1344–1351.
6. Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 2003; 63:1934–1943.
7. Cheung AK, Rocco MV, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006; 17:546–555.
8. Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of haemodialysis patients. J Am Soc Nephrol. 2009; 20:645–654.
9. Oates T, Pinney JH, Davenport A. Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin response. Am J Nephrol. 2011; 33:70–75.
10. Henderson LW, Silverstein ME, Ford CA, Lysaght MJ. Clinical response to maintenance hemodiafiltration. Kidney Int. 1975; 2:58–63.
11. Maduell F, Moreso F, Pons M, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013; 24:487–497.
12. Grooteman MP, van den Dorpel MA, Bots ML, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012; 23:1087–1096.
13. Farrington K, Davenport A. The ESHOL study: Haemodiafiltration improves survival-but how? Kidney Int. 2013; 83:979–981.
14. Meert N, Eloot S, Schepers E, et al. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities. Nephrol Dial Transplant. 2011;26:2624–2630.
15. Vernon K, Peasegood J, Riddell A, Davenport A. Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract. 2011; 117:c403–c408.
16. Davenport A. Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton). 2009; 14:455–461.
17. Booth J, Pinney J, Davenport A. Changes in red blood cell size and red cell fragmentation during hemodialysis. Int J Artif Organs. 2010; 33:900–905.
18. Persaud J, Thomas M, Davenport A. Indirect ion selective electrode methods potentially overestimate peritoneal dialysate sodium losses. Ther Apher Dial. 2014; 18:321–325.
19. Fürstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient haemodialysis patients. Am J Kidney Dis. 2011; 57:123–129.
20. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National Kidney Foundation. Am J Kidney Dis. 1997;30:S15–S66.
21. Sandeman SR, Howell CA, Phillips GJ, et al. An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med. 2014; 25:1589–1597.
22. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant. 2002; 17:1085–1092.
23. Viaene L, Meijers BK, Bammens B, Vanrenterghem Y, Evenepoel P. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function. Perit Dial Int. 2014; 34:71–78.
24. Meert N, Beerenhout C, Schepers E, Glorieux G, Kooman J, Vanholder R. Evolution of protein-bound uraemic solutes during predilution haemofiltration. J Nephrol. 2009; 22:352–357.
25. Meert N, Waterloos MA, Van Landschoot M, Dhondt A, Ledebo I, Glorieux G, Goeman J, Van der Eycken J, Vanholder R. Prospective evaluation of the change of predialysis protein-bound uraemic solute concentration with postdilution online haemodiafiltration. Artif Organs. 2010; 34:580–585.
26. Sirich TL, Luo FJ, Plummer NS, Hostetter TH, Meyer TW. Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant. 2012; 27:1574–1579.
27. Sirich TL, Aronov PA, Plummer NS, Hostetter TH, Meyer TW. Numerous protein-bound solutes are cleared by the kidney with high efficiency. Kidney Int. 2013; 84:585–590.
28. Wu IW, Hsu KH, Hsu HJ, et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients–a prospective cohort study. Nephrol Dial Transplant. 2012; 27:1169–1175.
29. Redinbo MR. The microbiota, chemical symbiosis, and human disease. J Mol Biol. 2014; 426:3877–3891.
30. Marzocco S, Dal Piaz F, Di Micco L, et al. Very low protein diet reduces indoxyl sulfate levels in chronic kidney disease. Blood Purif. 2013; 35:196–201.
31. Patel KP, Luo FJ, Plummer NS, Hostetter TH, Meyer TW. The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol. 2012; 7:982–988.
32. Scialla JJ, Appel LJ, Wolf M, et al. Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: The Chronic Renal Insufficiency Cohort study. J Ren Nutr. 2012; 22:379–388.e1.
33. Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in haemodialysis patients. Clin J Am Soc Nephrol. 2014; 9:1603–1610.
34. Nongnuch A, Davenport A. The effect of vegetarian diet on skin autofluorescence measurements in haemodialysis patients. Br J Nutr. 2015; 113:1040–1043.